AstraZeneca COVID-19 Vaccine Data ‘Not Sufficient’ For Approval In Switzerland
Swiss Update Comes As EMA Announces Rolling Review Of Novavax Vaccine
Switzerland's medicines agency says it wants to see more data on AZD1222 before it can approve the vaccine. Also, a rolling review of Novavax's NVX-CoV2373, yet another COVID‑19 vaccine, is under way at the European Medicines Agency.
